Sarepta Therapeutics
Price & Volume
Stats
See more52W Range | $10.42-$25.32 |
Market Cap | $2B |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $2.1B |
Revenue Growth (YoY) | -1.9% |
Gross Profit (12 Mos) | $470.7M |
Diluted EPS | $0.35 |
News
See moreYahoo Finance • 3 days ago
2 Beaten-Down Stocks That Still Aren't Worth Buying
Yahoo Finance • 15 days ago
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Breakthrough Pipelines Ignite Investor Excitement: Retatrutide, VERVE-102, NEO100, and More Set to Transform Medicine
Yahoo Finance • 2 months ago
My Top 3 Biotech Stocks for May 2026
About
CEO | Mr. Douglas S. Ingram Esq., J.D. |
CFO | Mr. Ryan H. Wong |
Address | 215 First Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 835 |